Seizures have been thyroidectomy and synthroid rarely with the institution of levothyroxine therapy. Pseudotumor cerebri and slipped capital femoral epiphysis have been reported in children receiving levothyroxine therapy. Check blood sugar levels closely.
synthroid can cause mentral changes
Notify your doctor immediately if you develop any if the following symptoms. If your brand may cause these effects, be sure to take your medicine with a full glass of water. Before taking this medication, tell your doctor if you have heart disease, coronary artery disease, anemia (lack of red blood cells), diabetes, problems with your pituitary or adrenal glands, or a thyroidectomy and synthroid of blood clots. Drugs that may decrease T4 5'-deiodinase activity Amiodarone Beta-adrenergic antagonists - (e.g., Propranolol > 160 mg/day) Glucocorticoids - (e.g., Dexamethasone ≥ 4 mg/day) Propylthiouracil (PTU) Administration of these enzyme inhibitors decreases the peripheral conversion of T4 to T3, leading to decreased T3 levels. Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed. Digitalis glycosides The therapeutic effects of digitalis glycosides may be reduced by levothyroxine. Patients who have antithyroid antibodies before treatment are at higher risk for thyroid dysfunction during treatment. For this medicine, the following should be considered: Allergies Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Visit your doctor regularly. However, in patients with high-risk tumors, the target thyroidectomy and synthroid for TSH suppression may be < 0.01 mU/L. Each tablet contains 100 mcg (0.1 mg) levothyroxine sodium. Overtreatment has been associated with craniosynostosis in infants, and may adversely affect the tempo of brain maturation and accelerate the bone age with resultant premature closure of the epiphyses and compromised adult stature. A lower starting dose (e.g., 25 mcg/day) should be considered in infants at risk for cardiac failure, and the dose should be increased in 4-6 weeks as needed based on clinical and laboratory response to treatment. Nervous system Nervous system side effects have rarely included seizures during initiation of therapy. Many drugs and physiologic conditions affect the binding of thyroid hormones to serum proteins (see PRECAUTIONS - Drug Interactions and Drug-Laboratory Test Interactions). You may report side effects to FDA at 1-800-FDA-1088. Blood and urine tests will be needed thyroidectomy and synthroid check for unwanted effects . Levothyroxine should not be used for the treatment of obesity or thyroidectomy and synthroid the purpose of losing weight.
Hence, the following recommendations serve only as dosing guidelines. In addition, confusion and disorientation may occur. Follow your doctor's dosing instructions and try to take this medication at the same time each day. thyroidectomy and synthroid is important to take Synthroid exactly as prescribed. It may also be used for other conditions as determined by your doctor. You should not use this medication if you have had a heart attack, a thyroid disorder called thyrotoxicosis, or an adrenal gland problem thyroidectomy and synthroid is not controlled by treatment. Taking levothyroxine over long periods of time may cause bone loss, which can lead to osteoporosis. Keep Synthroid out of the reach of children. Levothyroxine sodium is contraindicated if the serum TSH is already suppressed due to the risk of precipitating overt thyrotoxicosis (see CONTRAINDICATIONS - WARNINGS and PRECAUTIONS). Patients treated concomitantly with orlistat and levothyroxine should be monitored for changes in thyroid function. In patients with nontoxic diffuse goiter or nodular thyroid disease, particularly the elderly thyroidectomy and synthroid those with underlying cardiovascular disease, levothyroxine sodium therapy is contraindicated if the serum TSH level is already suppressed due to the risk of precipitating overt thyrotoxicosis (see CONTRAINDICATIONS). Version: 6.01. Notify your physician if you experience any of the following symptoms: rapid or irregular heartbeat, chest pain, shortness of breath, leg cramps, headache, nervousness, irritability, sleeplessness, tremors, change in appetite, weight gain or loss, vomiting, diarrhea, excessive sweating, heat intolerance, fever, changes in menstrual periods, hives or skin rash, or any other unusual medical event. In patients with severe hypothyroidism, the recommended initial levothyroxine sodium dose is 12.5-25 mcg/day with increases of 25 mcg/day every 2-4 weeks, accompanied by clinical and laboratory assessment, until the TSH level is normalized.